MiMedx Group Inc (MDXG) Stock Forecast & Price Target
MiMedx Group Inc · NASDAQ
$4.37+0.10 (+2.46%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering MiMedx Group Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $6.00 to $10.00, a moderate spread. The average target of $8.20 sits 88% above the current $4.37. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.00 next quarter toward $0.14 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to MiMedx Group Inc.
As of Jul, 5 of 5 firms rate MDXG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MDXG EPS & revenue forecast
EPS · NEXT QUARTER
$-0.00
Range $-0.01 – $0.01 · 3 analysts · -102% YoY
Next period, 3 analysts expect MiMedx Group Inc to earn $-0.00 a share (range $-0.01 – $0.01), versus $0.15 a year earlier. Full-year consensus is $-0.07, growing to $0.14 the year after.
REVENUE · NEXT QUARTER
$70.5M
Range $67.4M – $72.1M · 3 analysts · -38% YoY
Revenue is expected to reach $70.5M (range $67.4M – $72.1M), -38.0% year-over-year. Full-year consensus is $269.4M, rising to $302.9M next year.
Top analysts covering MiMedx Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MDXG.
#1
Chase Knickerbocker
Craig-Hallum · Rank #25
Buy
$7.00+60.4% to target
Overall win rate
58%
+ Follow
#2
Ross Osborn
Cantor Fitzgerald · Rank #139
Buy
$12.00+174.9% to target
Overall win rate
34%
+ Follow
#3
DT
David Turkaly
Citizens
Buy
$6.00+37.5% to target
Coverage
—
+ Follow
#4
Sarah James
Cantor Fitzgerald
Buy
$8.00+83.3% to target
Coverage
—
+ Follow
#5
Carl Byrnes
Northland Capital Markets
Buy
$6.00+37.5% to target
Coverage
—
+ Follow
MDXG stock forecast FAQ
What is MDXG's average 12-month price target?+
The 5 analysts with a live target average $8.20 for MiMedx Group Inc over the next 12 months, ranging from a $10.00 high to a $6.00 low.
Is MDXG stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MDXG?+
The Street-high target is $10.00 (Lake Street), and the Street-low is $6.00 (Citizens). The average of all 5 active targets is $8.20.
How many Wall Street analysts cover MDXG?+
5 analysts have an active rating on MiMedx Group Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering MDXG?+
Among analysts who currently cover MDXG, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #25). Their current call is Buy with a $7.00 target.
What is MiMedx Group Inc's projected EPS for next quarter?+
The consensus estimate is $-0.00 per share (range $-0.01 – $0.01) across 3 analysts. Full-year EPS is projected at $-0.07, rising to $0.14 the following year.
How much revenue is MiMedx Group Inc expected to report next quarter?+
Consensus revenue is $70.5M (range $67.4M – $72.1M). Full-year revenue is projected at $269.4M, growing to $302.9M next year.
Have analysts been upgrading or downgrading MDXG lately?+
As of Jul, 5 of 5 firms rate MDXG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MDXG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
